Panchakarma procedures in the management of Chronic Plaque Psoriasis

Comparative Efficacy Study of Shodhana and Shodhanottar Khadir Yavagupana and khadir Pariseka in Mandal Kustha w.s.r. to Chronic Plaque Psoriasis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029826

Enrollment

Registered

2020-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

Intervention1: Shodhana, Yavagupan and Pariseka: Shodhana (Vaman and Virechan) followed by Samsarjana Krama, and then Khadir Yavagupana and Pariseka of 45 minutes [11] for 7 days. Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 18 to 60 years of age. 2.Patients with the classical features of Mandal Kushtha (Chronic Plaque Psoriasis). 3.Patients not taking any other medicine for Mandal Kushtha (Chronic Plaque Psoriasis). 4.Patients fit for Vamana and Virechana 5.Patients willing to provide consent for trial.

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mothers. 2.Patients suffering from systemic disorders as Cardiac Problem, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy. 3.Patients suffering from Psoriatic arthritis.

Design outcomes

Primary

Measure	Time frame
change in PASI scoreTimepoint: 0 day, 45th day and 60th day	—

Secondary

Measure	Time frame
change in Dermatology Life Quality IndexTimepoint: 65 days	—

Countries

India

Contacts

Public ContactASHOK KUMAR REGAR

National Institute of Ayurveda Jaipur

sarveshksingh21@gmail.com8739860237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026